Renin-angiotensin-aldosterone system inhibitors - why they won't help in COVID-19
- PMID: 41331343
- DOI: 10.1038/s41440-025-02179-y
Renin-angiotensin-aldosterone system inhibitors - why they won't help in COVID-19
Keywords: ACEI; ARB; COVID-19; RAAS.
Conflict of interest statement
Compliance with ethical standards. Conflict of interest: The authors declare no competing interests.
References
-
- Matsuzawa Y, Tsujita K. Impact of SARS-CoV-2 variants on viral infectivity and the role of the renin-angiotensin-aldosterone system. Hypertens Res. 2025. https://doi.org/10.1038/s41440-025-02115-0 . Published online January 28 - DOI - PubMed
-
- Schaich CL, Chappell MC, Shotwell MS, et al. The Circulating Renin-Angiotensin System and Mortality among Patients Hospitalized for COVID-19: A Mechanistic Substudy of the ACTIV-4 Host Tissue Trials. Am J Physiol Lung Cell Mol Physiol. 2025. https://doi.org/10.1152/ajplung.00372.2024 . Published online January 30 - DOI - PubMed
-
- Chirinos JA, Cohen JB, Zhao L, et al. Clinical and Proteomic Correlates of PlasmaACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure [publishedcorrection appears in Hypertension. Hypertension. 2021;77:1526–36.
Publication types
LinkOut - more resources
Full Text Sources
